ClinicalTrials.gg
CompletedNCT05906160Updated Oct 19, 2026Results posted

PortionSize Study 3: Assessment in Free-living Conditions

An observational study in Dietary Habits, sponsored by Pennington Biomedical Research Center. Completed at 1 site in United States. Open to participants aged 18 Years to 62 Years. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Pennington Biomedical Research Center · Observational

How we know

Updated Oct 19, 2026Results postedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-crossover
Time perspective
Prospective
Enrollment
63
Ages
18 Years to 62 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 333 studies in Feeding Behavior with a site in United States — 46 open to participants now, 66 under way, 1 of them phase 3. Feeding Behavior · United States.

Enrollment
43rd of 62
63 · median 111
Started
2023
with 32 others
Observational
62 of 333
8 open now
Registered
258th of 333
by date
Lead sponsor
7 of 333
Pennington Biomedical Research Center

Among the 333 studies in Feeding Behavior with a site in United States, this one is the 43rd largest by enrollment of the 62 observational ones that give a count, is one of 33 that started in 2023, is one of 62 observational ones, and was the 258th registered.

Feeding Behavior

988 studies on the registry are indexed under Feeding Behavior; 177 are open to participants now.

Browse Feeding Behavior studies →

Open to participants now

46 of the 333 studies in Feeding Behavior with a site in United States are open now. Recruiting first, the newest first:

41 more — sign in →

All 46 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 112 Feeding Behavior studies recruiting now, 35 (31%) set no upper age limit and 71 (63%) stop at 75 or younger; 41 take children under 18; 70 take healthy volunteers.

This study: 18 Years to 62 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 333 studies in Feeding Behavior with a site in United States, or all of them as a file.
02

Study summary

The objective is to test the accuracy of the PortionSize™ app and the MyFitnessPal© app at measuring energy intake in free-living conditions, tested against the gold-standard, doubly labeled water. Participants will use PortionSize™ and MyFitnessPal apps in separate periods to test the accuracy of the respective apps.

Read the detailed description

We will recruit adults to use the PortionSize app and the MyFitnessPal free-living conditions. In a within subjects and randomized, counterbalanced design, the accuracy of the PortionSize and MyFitnessPal apps at estimating energy intake in free-living conditions will be tested against the gold-standard, doubly labeled water (DLW), over two non-consecutive four-day periods that should include at least one weekend day and encompass the same days of the week during each period. Participants will be trained in our clinic to use the apps prior to their use in free-living conditions. We will integrate customizable notifications and reminders to remotely prompt participants to record data, resolve data collection problems, etc. These notifications and reminders utilize Ecological Momentary Assessment (EMA) methodology to maximize data collection protocol adherence by reminding participants to capture and send food information at relevant times.

03

Conditions studied

  • Dietary Habits

Browse trials for

04

Who can participate

Ages eligible
18 Years to 62 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Adults aged 18-62, males and females.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female, age 18-62 years
  • (BMI) 18.5-50 kg/m2
  • Ownership of an iPhone model 9 or later, which the participant is willing to use for the study
  • Access to Apple ID, password, and email address and willing to use them during the study
  • Willing to use data and any accompanying charges as part of study participation
  • Willing to complete all study procedures and adhere to study visit timelines
  • Willing to be re-contacted for future research and/or follow-up

Exclusion criteria

Exclusion Criteria:

oHave been 6-month weight unstable (gain/loss >5% last 6 months) and/or active weight loss program

  • Any cardiometabolic disorder that significantly affects what or how much people eat
  • Active cancer diagnosis or treatment that significantly affects what or how much people eat, excluding some melanomas and other cancers
  • PBRC employee, as previous reviewers argued that they are not representative of the community (
  • 3rd member of the same household to participate (i.e. the 1st and 2nd members of the household cannot participate simultaneously)
  • Women who are currently pregnant or breastfeeding (self-reported)
  • Diagnosed with an uncontrolled thyroid disorder (controlled ≥ 3 months of medication)
  • Have had or plan to have weight loss surgery (gastric band removal may be allowed at PI discretion)
  • Consume >28 alcoholic beverages per week
  • Anyone severely
  • Serious digestive disorders that significantly affect what or how much people eat Fluid imbalance and/or on diuretic
  • Follows a diet mainly consisting of foods that study staff deems unquantifiable for this study (i.e., liquid supplements, gluten-free specialty items) or consumes a high quantity of specialty foods
  • Any condition or circumstance that, in the judgement of the PIs, couldimpede study completion
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Observational model
Case-crossover
Time perspective
Prospective
Enrollment
63 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Energy (Kilocalorie or kcal) Intake

    Mean difference in measured energy intake between PortionSize (and MyFitnessPal) and the criterion measure (DLW). These analyses will rely on equivalence testing using the Two One-side T-test (TOST) method. The null hypothesis of an equivalence tests is that the means are nonequivalent, i.e., the confidence interval of the mean of the test condition exceeds the pre-specified error bound. The alternative hypothesis is that the means are equivalent, and the mean difference between the experimental method and gold standard is hypothesized to be zero. Mean differences were calculated as mean daily energy intake estimated from DLW subtracted from the mean energy intake measured by each of the tested apps. Therefore, negative values indicate an underestimation while positive values indicate an overestimation.

    Time frame: 4 days for each app (PortionSize and MyFitnessPal) and an overlapping 12 days for DLW

07

Results

Posted Oct 19, 2026

Participant flow

Period 1
Participant flow — Period 1
MilestonePortionSizeMyFitnessPal
Started3231
Completed3231
Not completed00
Period 2
Participant flow — Period 2
MilestonePortionSizeMyFitnessPal
Started3231
Completed3231
Not completed00

Outcome measures

PrimaryEnergy (Kilocalorie or kcal) Intake

Mean difference in measured energy intake between PortionSize (and MyFitnessPal) and the criterion measure (DLW). These analyses will rely on equivalence testing using the Two One-side T-test (TOST) method. The null hypothesis of an equivalence tests is that the means are nonequivalent, i.e., the confidence interval of the mean of the test condition exceeds the pre-specified error bound. The alternative hypothesis is that the means are equivalent, and the mean difference between the experimental method and gold standard is hypothesized to be zero. Mean differences were calculated as mean daily energy intake estimated from DLW subtracted from the mean energy intake measured by each of the tested apps. Therefore, negative values indicate an underestimation while positive values indicate an overestimation.

Time frame:
4 days for each app (PortionSize and MyFitnessPal) and an overlapping 12 days for DLW
Reported as:
Mean · kcal/day
Energy (Kilocalorie or kcal) Intake
kcal/dayPortionSizeMyFitnessPal
Energy (Kilocalorie or kcal) Intake-1055.7 ± 802.7-734.8 ± 628.5

Adverse events

Collected over 4 days in free-living conditions per testing period. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
PortionSize0/32 (0%)0/32 (0%)0/32 (0%)
MyFitnessPal0/31 (0%)0/31 (0%)0/31 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)PortionSizeMyFitnessPalTotal
Mean35.22 ± 11.740.74 ± 12.937.9 ± 12.5
Sex: Female, Male
Sex: Female, Male(Participants)PortionSizeMyFitnessPalTotal
Female181533
Male141630
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)PortionSizeMyFitnessPalTotal
Hispanic or Latino224
Not Hispanic or Latino302959
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)PortionSizeMyFitnessPalTotal
American Indian or Alaska Native000
Asian202
Native Hawaiian or Other Pacific Islander101
Black or African American8917
White202242
More than one race101
Unknown or Not Reported000
08

Study locations

1 site
  • Pennington Biomedical Research Center
    Baton Rouge, Louisiana 70808, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2023 to primary completion in Nov 2024, 17 months.

Results were first posted in Oct 2026, 1 year 10 months after primary completion.

Of 100 non-industry observational studies under Feeding Behavior, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 62. This study's 17 months is below that.

Counting every sponsor, half of 101 studies reached it within 24 months; a quarter within 8 and three quarters within 62.

How these figures are worked out, and which studies are left out of them.

Registered
May 26, 2023
First posted
Jun 15, 2023
StartActual
Jun 22, 2023
Primary completionActual
Nov 25, 2024
CompletionActual
Mar 31, 2026
Results first posted
Oct 19, 2026
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 19, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedEnergy Intake ((Kilocalorie or kcal) IntakeTime frame: May 2023 through February 2025 → 4 days for each app (PortionSize and MyFitnessPal) and an overlapping 12 days for DLW
Oct 19, 2026
Documents
Show all 1 update
  1. Oct 19, 2026
    Results posted
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedEnergy Intake ((Kilocalorie or kcal) IntakeTime frame: May 2023 through February 2025 → 4 days for each app (PortionSize and MyFitnessPal) and an overlapping 12 days for DLW
    + 2 other changes: verification date and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05906160
Responsible party
Corby K. Martin (Professor, Director, Ingestive Behavior Laboratory, Pennington Biomedical Research Center) — Principal investigator
First posted
Jun 15, 2023
Start date
Jun 22, 2023
Primary completion
Nov 25, 2024
Completion
Mar 31, 2026
Results posted
Oct 19, 2026
Last update
Oct 19, 2026

Study contacts

John W Apolzan, Ph.D.
principal investigator · Pennington Biomedical Research Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion